Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial. | BMC Gastroenterol | 2020 | 33213378 | PubTator, text mining | PubMed |
| Daily Monitoring of Serum Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein Is Useful for Predicting Therapeutic Effect of Tolvaptan in Cirrhotic Ascites. | Tohoku J Exp Med | 2020 | 33208569 | PubTator, text mining | PubMed |
| Differential expression of epithelial sodium channels in human RCC associated with the prognosis and tumor stage: Evidence from integrate analysis. | J Cancer | 2020 | 33193899 | PubTator, text mining | PubMed |
| Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists. | Front Endocrinol (Lausanne) | 2020 | 33193084 | PubTator, text mining | PubMed |
| Effect of Vasopressin on the Hypothalamic-Pituitary-Adrenal Axis in ADPKD Patients during V2 Receptor Antagonism. | Am J Nephrol | 2020 | 33147589 | PubTator, text mining | PubMed |
| Management of hyponatremia associated with acute porphyria-proposal for the use of tolvaptan. | Ann Transl Med | 2020 | 33145317 | PubTator, text mining | PubMed |
| SLE: Novel Postulates for Therapeutic Options. | Front Immunol | 2020 | 33117397 | PubTator, text mining | PubMed |
| Validation of a next-generation sequencing (NGS) panel to improve the diagnosis of X-linked hypophosphataemia (XLH) and other genetic disorders of renal phosphate wasting. | Eur J Endocrinol | 2020 | 33107440 | PubTator, text mining | PubMed |
| Association of Volume Overload With Kidney Function Outcomes Among Patients With Heart Failure With Reduced Ejection Fraction. | Kidney Int Rep | 2020 | 33102958 | PubTator, text mining | PubMed |
| Congenital nephrogenic diabetes insipidus presenting with bilateral hydronephrosis and dilatation of the ureter and bladder. | Acute Med Surg | 2020 | 33101696 | PubTator, text mining | PubMed |
| Genetic Aspects in Shoulder Disorders. | Rev Bras Ortop (Sao Paulo) | 2020 | 33093716 | PubTator, text mining | PubMed |
| Oxytocin Elicits Itch Scratching Behavior via Spinal GRP/GRPR System. | Front Neurosci | 2020 | 33071749 | PubTator, text mining | PubMed |
| Precise Genome Editing in Poultry and Its Application to Industries. | Genes (Basel) | 2020 | 33053652 | PubTator, text mining | PubMed |
| A snake toxin as a theranostic agent for the type 2 vasopressin receptor. | Theranostics | 2020 | 33052234 | PubTator, text mining | PubMed |
| Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. | Front Pediatr | 2020 | 33042923 | PubTator, text mining | PubMed |
| Safety and Tolerability of Tolvaptan in an Autosomal Dominant Polycystic Kidney Disease Spanish Cohort: A Real-World Experience. | Cureus | 2020 | 33033683 | PubTator, text mining | PubMed |
| Multiple sclerosis: early indicators of disease and assessing future risk. | J Neurol | 2020 | 33030606 | PubTator, text mining | PubMed |
| Nocturnal Urine Production in Women With Global Polyuria. | Int Neurourol J | 2020 | 33017897 | PubTator, text mining | PubMed |
| Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation. | Sci Rep | 2020 | 33009446 | PubTator, text mining | PubMed |
| Naphthalenediimides with Cyclic Oligochalcogenides in Their Core. | Chemistry | 2020 | 33006168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=47